RIO DE JANEIRO, BRAZIL - After plans to buy India's Covaxin vaccine fell through in the wake of a series of charges filed in Covid's CPI against the product's representative in Brazil, the country's private vaccination clinics face a double hurdle to participate in the campaign against coronavirus.
It's a zero-sum game. First, they must find a vaccine, since the major laboratories all have contracts with governments. Then, they must contend with legislation that today allows for the private purchase of vaccines, as long as half are given to patients for free, and the other . . .
This content is restricted to subscribers